Hidradénite suppurée (maladie de Verneuil);Hidradenitis suppurativa

Presse Medicale

Volumn 39, Issue 12, 2010, Pages 1254-1264

  Revuz, Jean ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; CYPROTERONE ACETATE; DAPSONE; ESTROGEN; ETANERCEPT; ETRETIN; ETRETINATE; FINASTERIDE; INFLIXIMAB; ISOTRETINOIN; LITHIUM; METRONIDAZOLE; ORAL CONTRACEPTIVE AGENT; RIFAMPICIN; STEROID; TETRACYCLINE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA;

ACNE; ATTITUDE TO HEALTH; BACTERIAL INFECTION; CELLULITIS; CHRONICITY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMMUNITY MEDICINE; CROHN DISEASE; DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HEREDITY; HUMAN; INCISION; LOADING DRUG DOSE; LYMPHEDEMA; MALIGNANT ATROPHIC PAPULOSIS; OBESITY; PAIN; PATHOLOGY; PREVALENCE; QUALITY OF LIFE; RECURRENT DISEASE; REINFECTION; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX RATIO; SHORT SURVEY; SKIN ABSCESS; SKIN DEFECT; SKIN INFLAMMATION; SKIN MANIFESTATION; SKIN NODULE; SMOKING; SUPPURATIVE HIDRADENITIS; SYMPTOMATOLOGY; TOPOGRAPHY; DRUG ANTAGONISM; PSYCHOLOGICAL ASPECT; REVIEW;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HIDRADENITIS SUPPURATIVA; QUALITY OF LIFE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649907206     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.08.003     Document Type: Short Survey

References (73)

1. Verneuil A. Études sur les tumeurs de la peau; de quelques maladies des glandes sudoripares. Arch Gen Med 1854, 4:447-468.
2. Shelley W.B., Cahn M.M. The pathogenesis of hidradenitis suppurativa in man. Arch Dermatol 1955, 72:562-565.
3. Yu C.C.W., Cook M.G. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990, 122:763-769.
4. Plewig G., Kligman A.M. Acne morphogenesis and treatment 1975, 192-193. Springer, Berlin, Heidelberg, New York.
5. Hidradenitis Suppurativa Foundation. San Diego, California 92129. www.hs-foundation.org.
6. Naldi L. Epidemioloy. Hidradenitis suppurativa 2006, 58-64. Springer, Berlin (Germany). G.B. Jemec, J. Revuz, J. Leyden (Eds.).
7. Revuz J.E., Canoui-Poitrine F., Wolkenstein P., Viallette C., Gabison G., Pouget F., et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control. J Am Acad Dermatol 2008, 59:596-601.
8. Jemec G.B. The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988, 119:345-350.
9. Jemec G.B., Heidenheim M., Nielsen N.H. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996, 35:191-194.
10. Morgan W.P., Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol 1982, 118:101-102.
11. Poli F., Jemec G.B., Revuz J. Clinical presentation. Hidradenitis Suppurativa 2006, 11-24. Springer, Heidelberg. G.B. Jemec, J. Revuz, J. Leyden (Eds.).
12. Wortsman X., Revuz J., Jemec G.B. Lymph nodes in hidradenitis suppurativa. Dermatology 2009, 219:22-24.
13. von der Werth J.M., Williams H.C. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000, 14:389-392.
14. Canoui-Poitrine F., Revuz J., Wolkenstein P., Viallette C., Gabison G., Pouget F., et al. Clinical characteristics of a series of 302 French patients suffering from hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009, 61:51-57.
15. Hurley H.J. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. Dermatologic surgery 1989, 729-739. Marcel Dekker, New York. R.K. Roenigk, H.H. Roenigk (Eds.).
16. von der Werth J.M., Jemec G.B. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001, 144:809-813.
17. Wolkenstein P., Loundou A., Barrau K., Auquier P., Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007, 56:621-623.
18. Faye O., Petit F., Poli F., Petit T., Wechsler J., Gabison G., et al. Lymphœdème compliquant une hidradénite suppurée: trois observations. Ann Dermatol Venereol 2007, 134:567-569.
19. Maalouf E., Faye O., Poli F., Cosnes A., Revuz J. Carcinome épidermoïde mortel sur hidradénite suppurée après traitement par Infliximab. Ann Dermatol Venereol 2006, 133:473-474.
20. Jemec G.B., Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology 1997, 194:325-328.
21. Bedlow A.J., Mortimer P.S. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol 1996, 21:305-306.
22. Seksik P, Contou JF, Cosnes A, Cosnes J; hidradenitis suppurativa and Crohn's disease. In: Hidradenitis suppurativa Jemec G, Revuz J, Leyden J editors; Berlin; Germany, 1 vol: Springer. 2006, p. 50-7.
23. Church J.M., Fazio V.W., Lavery I.C., Oakley J.R., Milsom J.W. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis 1993, 8:117-119.
24. Kurzen H., Kurokawa I., Jemec G.B.E., Emtestam L., Sellheyer K., Giamarellos-Bourboulis E.J., et al. What causes hidradenitis suppurativa?. Exp Dermatol 2008, 17:455-472.
25. Jemec G.B., Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996, 34:994-999.
26. Sellheyer K., Krahl D. Hidradenitis suppurativa is acne inversa! An appeal to finally abandon a misnomer. Int J Dermatol 2005, 44:535.
27. Kurokawa I., Nishijima S., Kusumoto K. Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). J Int Med Res 2002, 30:131-136.
28. Jemec G.B.E., Gniadecka M. Ultrasound examination of hair follicles in hidradenitis. Arch Dermatol 1997, 133:967-972.
29. Kelly A.M., Cronin P. MRI features of hidradenitis suppurativa and review of the literature. Am J Roentgenol 2005, 185:1201-1204.
30. Von Der Werth J.M., Williams H.C., Raeburn J.A. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000, 142:947-953.
31. Von der Werth J., Wood P., Irvine A.D., Irwin Mclean W.H. Genetics of hidradenitis suppurativa. Hidradenitis suppurativa 2006, 70-83. Springer, Berlin (Germany). G. Jemec, J. Revuz, J. Leyden (Eds.).
32. Gao M., Wang P.G., Cui Y., Yang S., Zhang Y.H., Lin D., et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol 2006, 126:1302-1306.
33. Nassar D., Hugot J.P., Wolkenstein P., Revuz J. Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: a pilot study. Dermatology 2007, 215(4):359.
34. Lapins J., Olerup O., Emtestam L. No human leukocyte antigen-A-B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm Venereol. 2001, 81:28-30.
35. Oprica C., Nord C.E. Bacteriology of hidradenitis suppurativa. Hidradenitis suppurativa 2006, 86-93. Springer, Berlin (Germany). G. Jemec, J. Revuz, J. Leyden (Eds.).
36. Harrison B.J., Kumar S., Read G.F., Edwards C.A., Scanlon M.F., Hughes L.E., et al. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg 1985, 72:1002-1004.
37. Barth J.H., Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br J Dermatol 1991, 125:304-308.
38. Giamarellos-Bourboulis E.J., Antonopoulou A., Petropoulou C., Mouktaroudi, Spyridaki E., Baziaka F., et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 2007, 156:51-56.
39. Hunger R.E., Surovy A.M., Hassan A.S., Braathen L.R., Yawalkar N. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 2008, 158:691-697.
40. Gupta A.K., Knowles S.R., Gupta M.A., Jaunkalns R., Shear N.H. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995, 32:382-386.
41. Mahe E., Morelson E., Lechaton S., Sang K.H., Mansouri R., Ducasse M.F., et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation 2005, 79:476-482.
42. Sartorius K., Lapins J., Emtestam L., Jemec G.B. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003, 149:211-213.
43. Revuz J Modifications et mode d'emploi du score de Sartorius pour évaluer la gravité de l'hidradénite suppurée. Ann Dermatol Venereol 2007, 134:173-180.
44. Sartorius K., Emtestam L., Jemec G.B., Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009, 161:831-839.
45. Revuz J. Place de la chirurgie dans le traitement de l'hidradénite suppurée. Ann Dermatol Venereol 2008, 135:349-350.
46. Sartorius K., Boer J., Jemec G.B.E. Topical treatment in Hidradenitis suppurativa 2006, 150-160. Springer, Berlin (Germany). G. Jemec, J. Revuz, J. Leyden (Eds.).
47. Fearfield L.A., Staughton R.C. Severe vulval apocrin acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol 1999, 24:189-192.
48. O'Malley G.F., Dominici P., Giraldo P., Aguilera E., Verma M., Lares C., et al. Routine packing of simple cutaneous abscesses is painful and probably unnecessary. Acad Emerg Med 2009, 16:470-473.
49. Gener G., Canoui-Poitrine F., Revuz J., Faye O, Poli F., Gabison G., et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009, 219:148-154.
50. Mendonça C.O., Griffiths C.E. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006, 154:977-978.
51. Hessel H., van der Zee1, Boer J., Prens E.P., Jemec G.B.E. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009, 219:143-147.
52. Mortimer P.S., Dawber R.P.R., Gales M.A., Moore R.A. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986, 115:263-268.
53. Joseph M.A., Jayaseelan E., Ganapathi B., Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat 2005, 16:75-78.
54. Farrell A.M, Randall V.A., Vafaee T., Dawber R.P. Finasteride as a therapy forhidradenitis suppurativa. Br J Dermatol 1999, 141:1138-1139.
55. Boer J., van Gemert M.J. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999, 40:73-76.
56. Soria A., Canoui-Poitrine F., Wolkenstein P., Poli F., Gabison G., Pouget F., et al. Absence of efficacy of oral isotretinoin in Hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology 2009, 218:134-135.
57. Boer J. Oral retinoids for Hidradenitis suppurativa. Hidradenitis suppurativa 2006, 150-160. Springer, Berlin (Germany). G. Jemec, J. Revuz, J. Leyden (Eds.).
58. Kaur M.R., Lewis H.M. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatol Treat 2006, 17:211-213.
59. Haslund P., Lee R.A., Jemec G.B. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009, 89:595-600.
60. Fardet L., Dupuy A., Kerob D., Levy A., Allez M., Begon E. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007, 56:624-628.
61. Lee R.A., Dommasch E., Treat J., Sciacca-Kirby J., Chachkin S., Williams J., et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2009, 60:565-573.
62. Grant A., Gonzalez T., Montgomery M.O., Cardenas V., Kerdel F.A. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol 2010, 62:205-217.
63. Brunasso A.M., Delfino C., Massone C. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?. Br J Dermatol 2008, 159:761-763.
64. Fröhlich D., Baaske D., Glatzel M. Radiotherapy of hidradenitis suppurativa-still valid today?. Strahlenther Onkol 2000, 176:286-289.
65. Lapins J., Emtestam L Surgery. Hidradenitis suppurativa 2006, 160-173. Springer, Berlin (Germany). G. Jemec, J. Revuz, J. Leyden (Eds.).
66. Jemec G.B. Effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol 1988, 18:1103-1107.
67. Barron J. The surgical treatment of peri anal hidradenitis suppurativa. Dis Colon Rectum 1970, 13:441-443.
68. 2 laser stripping-secondary intention technique. Br J Dermatol 1994, 131:551-556.
69. Lapins J., Sartorius K., Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 2002, 47:280-285.
70. Mahmoud B.H., Tierney E., Hexsel C.L., Pui J., Ozog D.M., Hamzavi I.H. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminium-garnet laser. J Am Acad Dermatol 2010, 62:637-645.
71. Tierney E., Mahmoud B.H., Hexsel C., Ozog D., Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg 2009, 35:1188-1198.
72. O'Reilly D.J., Pleat J.M., Richards A.M. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg 2005, 116:1575-1576.
73. Strauss R.M., Pollock B., Stables G.I., Goulden V., Cunliffe W.J. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 2005, 152:803-804.